We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Bladder Cancer

Journal Scan / Research · July 14, 2021

Rucaparib Not Effective in Previously Treated, Locally Advanced or Metastatic Urothelial Carcinoma

BMC Cancer

 

Additional Info

BMC Cancer
Efficacy and Safety of Rucaparib in Previously Treated, Locally Advanced or Metastatic Urothelial Carcinoma From a Phase 2, Open-Label Trial (ATLAS)
BMC Cancer 2021 May 24;21(1)593, P Grivas, Y Loriot, R Morales-Barrera, MY Teo, Y Zakharia, S Feyerabend, NJ Vogelzang, E Grande, N Adra, A Alva, A Necchi, A Rodriguez-Vida, S Gupta, DH Josephs, S Srinivas, K Wride, D Thomas, A Simmons, A Loehr, RL Dusek, D Nepert, S Chowdhury

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading